Cantor Fitzgerald L. P. Makes New Investment in Amedisys, Inc. (NASDAQ:AMED)

Cantor Fitzgerald L. P. bought a new position in Amedisys, Inc. (NASDAQ:AMED - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 17,000 shares of the health services provider's stock, valued at approximately $1,543,000. Cantor Fitzgerald L. P. owned 0.05% of Amedisys as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Vanguard Group Inc. lifted its position in Amedisys by 0.3% in the 4th quarter. Vanguard Group Inc. now owns 3,216,120 shares of the health services provider's stock worth $291,992,000 after buying an additional 10,817 shares in the last quarter. Pentwater Capital Management LP increased its stake in shares of Amedisys by 178.3% in the fourth quarter. Pentwater Capital Management LP now owns 1,180,000 shares of the health services provider's stock worth $107,132,000 after acquiring an additional 756,000 shares during the last quarter. Norges Bank acquired a new stake in Amedisys during the fourth quarter valued at $83,061,000. Alpine Associates Management Inc. boosted its position in Amedisys by 3.2% during the fourth quarter. Alpine Associates Management Inc. now owns 888,120 shares of the health services provider's stock valued at $80,632,000 after purchasing an additional 27,403 shares during the last quarter. Finally, Wealthfront Advisers LLC purchased a new position in Amedisys in the fourth quarter valued at about $72,970,000. Institutional investors and hedge funds own 94.36% of the company's stock.

Analysts Set New Price Targets

AMED has been the subject of several research reports. Royal Bank of Canada reiterated an "outperform" rating and set a $100.00 price target on shares of Amedisys in a report on Wednesday, April 16th. Stephens reiterated an "equal weight" rating and issued a $101.00 target price on shares of Amedisys in a research note on Tuesday, March 4th. Four equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, Amedisys has an average rating of "Hold" and an average target price of $100.75.

Amedisys Stock Performance

AMED traded up $0.16 on Friday, hitting $95.36. The company had a trading volume of 242,075 shares, compared to its average volume of 415,135. Amedisys, Inc. has a 1-year low of $82.15 and a 1-year high of $98.95. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. The company's fifty day moving average price is $92.97 and its 200 day moving average price is $91.69. The stock has a market cap of $3.13 billion, a price-to-earnings ratio of 37.84, a price-to-earnings-growth ratio of 1.78 and a beta of 0.96.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.13 by $0.12. The business had revenue of $594.78 million during the quarter, compared to the consensus estimate of $597.43 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. Amedisys's quarterly revenue was up 4.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.03 EPS. Equities analysts predict that Amedisys, Inc. will post 4.4 earnings per share for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.